MBL

Anti-CD321 (F11R/JAM-A) (Human) mAb

Product Code:
 
MBL-W092-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2b κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
3G5B9
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-W092-3100 ul£345.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications:
FCM - 1-10 ug/mL
Background:
CD321, also known as F11 receptor (F11R), JAM-A, or JAM1, is a member of the immunoglobulin superfamily. CD321 is an important regulator of tight junction assembly in epithelial cells. Overexpression of CD321 has been observed in invasive breast cancer, and is also associated with poor survival in pancreatic and endometrial cancers.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 50848
Immunogen Translated:
Human F11R expressed Ba/F3 transfectants generated from SST-REX (signal sequence trap by retrovirus-mediated expression screening).
Reactivity:
This antibody reacts with human CD321 (F11R/JAM-A) on Flow cytometry.
Source:
This antibody was purified from hybridoma culture supernatant by Protein A affinity column chromatography.
Target:
CD321 (F11R/JAM-A) (Human)

Documents

References

1) Fong, D., et al., Ann. Surg. Oncol. 13, 4330-4336 (2012) 2) McSherry, E. A., et al., Int. J. Cancer 125, 1343-1351 (2009) 3) Koshiba, H., et al., Int. J. Gynecol. Cancer 19, 208-213 (2009) 4) Naik, U. P., et al., J. Cell Sci. 114, 539-547 (2001) 5) Kojima, T. and Kitamura,T., Nat. Biotechnol. 17, 487-490 (1999)